Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
Open Access
- 2 February 2021
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 12 (3), 209-220
- https://doi.org/10.18632/oncotarget.27874
Abstract
Https://doi.org/10.18632/oncotarget.27874 Venkata S.K. Manem, Olga Sazonova, Andréanne Gagné, Michèle Orain, Babak Khoshkrood-Mansoori, Nathalie Gaudreault, Yohan Bossé, Philippe JoubertKeywords
This publication has 47 references indexed in Scilit:
- Outcome and Prognostic Factors in Bronchial Carcinoids: A Single-Center ExperienceJournal of Thoracic Oncology, 2013
- Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methodsNucleic Acids Research, 2013
- Clinical impact of ki-67 labeling index in non-small cell lung cancerLung Cancer, 2013
- Pathway-based classification of cancer subtypesBiology Direct, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanomaBMC Cancer, 2010
- ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung: Distribution and Impact on SurvivalJournal of Thoracic Oncology, 2010
- Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic indexHistopathology, 2006
- Neuroendocrine Neoplasms of the Lung: A Prognostic SpectrumJournal of Clinical Oncology, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005